Fundz

Lila Bio Appoints Kimberly Ma as Chief Development Officer

PRIVATEOct 06, 2026

Position

Chief Development Officer

Company

Lila Biologics

Kimberly Ma
SeattleBiotechnology

Description

Lila Bio has announced the appointment of Kimberly Ma as Chief Development Officer. With over 20 years of experience in oncology drug development, Ms. Ma will lead the company's efforts in clinical development.

Company Information

Company

Lila Biologics

Location

1616 Eastlake Ave East, Suite 208

Seattle, Washington, United States

Fundz sees it the moment Lila Biologics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lila Biologics's next move

Learn about Strategic plan

Lila Biologics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.